138.93 USD
+3.96
2.93%
At close Apr 23, 4:00 PM EDT
After hours
138.93
+0.00
0.00%
1 day
2.93%
5 days
-5.52%
1 month
-7.63%
3 months
-18.23%
6 months
-14.65%
Year to date
-7.27%
1 year
3.75%
5 years
89.41%
10 years
66.56%
 

About: DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Employees: 70,000

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

25% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 5 (+1) [Q4]

4% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 78

1.12% less ownership

Funds ownership: 84.65% [Q3] → 83.53% (-1.12%) [Q4]

1% less funds holding

Funds holding: 590 [Q3] → 583 (-7) [Q4]

10% less capital invested

Capital invested by funds: $12.1B [Q3] → $11B (-$1.18B) [Q4]

30% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 241

73% less call options, than puts

Call options by funds: $149M | Put options by funds: $555M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$169
22%
upside
Avg. target
$169
22%
upside
High target
$169
22%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Barclays
Andrew Mok
28% 1-year accuracy
16 / 57 met price target
22%upside
$169
Equal-Weight
Maintained
18 Feb 2025

Financial journalist opinion

Based on 13 articles about DVA published over the past 30 days

Neutral
Zacks Investment Research
1 day ago
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note
In the latest trading session, DaVita HealthCare (DVA) closed at $134.97, marking a +1.1% move from the previous day.
DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note
Positive
The Motley Fool
4 days ago
3 No-Brainer Warren Buffett Stocks to Buy Right Now
In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has weathered every market storm and consistently outperformed market benchmarks.
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Negative
The Motley Fool
5 days ago
Why DaVita Stock Got Rocked This Week
We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors.
Why DaVita Stock Got Rocked This Week
Neutral
Zacks Investment Research
6 days ago
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
Negative
WSJ
1 week ago
DaVita Says Ransomware Attack Affecting Some Operations
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.
DaVita Says Ransomware Attack Affecting Some Operations
Negative
Reuters
1 week ago
Dialysis firm DaVita hit by ransomware attack
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.
Dialysis firm DaVita hit by ransomware attack
Positive
Zacks Investment Research
1 week ago
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
4 Stocks to Watch in a Dynamic Outpatient Home Health Industry
Negative
Zacks Investment Research
3 weeks ago
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
Positive
Market Watch
3 weeks ago
These 15 stocks are the most profitable companies in the S&P 500
Keeping it simple is a good idea when it comes to investing in high-quality, defensive value stocks — especially now.
These 15 stocks are the most profitable companies in the S&P 500
Negative
The Motley Fool
3 weeks ago
Warren Buffett Sold These 12 Stocks Over the Past 6 Months: Should You Sell Them Too?
Warren Buffett is known for the stocks he buys. He's had some big winners through the years.
Warren Buffett Sold These 12 Stocks Over the Past 6 Months: Should You Sell Them Too?
Charts implemented using Lightweight Charts™